Emerging Challenges of Preclinical Models of Anti-tumor Immunotherapeutic Strategies Utilizing Vγ9Vδ2 T Cells
出版年份 2020 全文链接
标题
Emerging Challenges of Preclinical Models of Anti-tumor Immunotherapeutic Strategies Utilizing Vγ9Vδ2 T Cells
作者
关键词
-
出版物
Frontiers in Immunology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-05-22
DOI
10.3389/fimmu.2020.00992
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells
- (2020) Marc Rigau et al. SCIENCE
- Butyrophilin-2A1 Directly Binds Germline-Encoded Regions of the Vγ9Vδ2 TCR and Is Essential for Phosphoantigen Sensing
- (2020) Mohindar M. Karunakaran et al. IMMUNITY
- Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma
- (2019) Mohammed Alnaggar et al. Journal for ImmunoTherapy of Cancer
- Ex vivo expanded patient-derived γδ T-cell immunotherapy enhances neuroblastoma tumor regression in a murine model
- (2019) Jaquelyn T. Zoine et al. OncoImmunology
- Vitamin C promotes the proliferation and effector functions of human γδ T cells
- (2019) Léonce Kouakanou et al. Cellular & Molecular Immunology
- NKG2D controls natural reactivity of Vγ9Vδ2 T lymphocytes against mesenchymal glioblastoma cells
- (2019) Cynthia Chauvin et al. CLINICAL CANCER RESEARCH
- Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies
- (2019) Zsolt Sebestyen et al. NATURE REVIEWS DRUG DISCOVERY
- Combined chemotherapy and allogeneic human Vγ9Vδ2 T lymphocyte-immunotherapies efficiently control the development of human epithelial ovarian cancer cells in vivo
- (2019) Noémie Joalland et al. OncoImmunology
- Humanized Mouse Models for the Preclinical Assessment of Cancer Immunotherapy
- (2018) Anja Kathrin Wege BIODRUGS
- IL-21 Increases the Reactivity of Allogeneic Human Vγ9Vδ2 T Cells Against Primary Glioblastoma Tumors
- (2018) Noémie Joalland et al. JOURNAL OF IMMUNOTHERAPY
- Correction to: Gamma-delta (γδ) T cells: friend or foe in cancer development?
- (2018) Yijing Zhao et al. Journal of Translational Medicine
- The Generation and Application of Patient-Derived Xenograft Model for Cancer Research
- (2018) Jaeyun Jung et al. Cancer Research and Treatment
- Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer
- (2018) Timm Hoeres et al. Frontiers in Immunology
- Towards Deciphering the Hidden Mechanisms That Contribute to the Antigenic Activation Process of Human Vγ9Vδ2 T Cells
- (2018) Lola Boutin et al. Frontiers in Immunology
- GMP-Grade Manufacturing of T Cells Engineered to Express a Defined γδTCR
- (2018) Trudy Straetemans et al. Frontiers in Immunology
- Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local
- (2018) C. David Pauza et al. Frontiers in Immunology
- Boosting γδ T cell-mediated antibody-dependent cellular cytotoxicity by PD-1 blockade in follicular lymphoma
- (2018) Cédric Rossi et al. OncoImmunology
- A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells
- (2017) Renée C. G. de Bruin et al. OncoImmunology
- Humanized Mouse Xenograft Models: Narrowing the Tumor–Microenvironment Gap
- (2016) J. Jason Morton et al. CANCER RESEARCH
- Stereotaxic administrations of allogeneic human Vγ9Vδ2 T cells efficiently control the development of human glioblastoma brain tumors
- (2016) Ulrich Jarry et al. OncoImmunology
- BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemia
- (2016) Audrey Benyamine et al. OncoImmunology
- Evolution and function of the TCR Vgamma9 chain repertoire: It’s good to be public
- (2015) C. David Pauza et al. CELLULAR IMMUNOLOGY
- The prognostic landscape of genes and infiltrating immune cells across human cancers
- (2015) Andrew J Gentles et al. NATURE MEDICINE
- Five Layers of Receptor Signaling in γδ T-Cell Differentiation and Activation
- (2015) Sérgio T. Ribeiro et al. Frontiers in Immunology
- Molecules and Mechanisms Implicated in the Peculiar Antigenic Activation Process of Human Vγ9Vδ2 T Cells
- (2015) Christelle Harly et al. Frontiers in Immunology
- NKG2D- and T-cell receptor-dependent lysis of malignant glioma cell lines by human γδ T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitors
- (2015) Guranda Chitadze et al. OncoImmunology
- Successful adoptive transfer and in vivo expansion of haploidentical γδ T cells
- (2014) Martin Wilhelm et al. Journal of Translational Medicine
- Preclinical research: Make mouse studies work
- (2014) Steve Perrin NATURE
- Tumor-Infiltrating γδ T Lymphocytes: Pathogenic Role, Clinical Significance, and Differential Programing in the Tumor Microenvironment
- (2014) Elena Lo Presti et al. Frontiers in Immunology
- γδ T cells for cancer immunotherapy
- (2014) Jonathan PH Fisher et al. OncoImmunology
- Repeated Systemic Administrations of Both Aminobisphosphonates and Human V 9V 2 T Cells Efficiently Control Tumor Development In Vivo
- (2013) T. Santolaria et al. JOURNAL OF IMMUNOLOGY
- Targeting lipid biosynthesis and salvage in apicomplexan parasites for improved chemotherapies
- (2013) Isabelle Coppens NATURE REVIEWS MICROBIOLOGY
- Chemotherapy Sensitizes Colon Cancer Initiating Cells to Vγ9Vδ2 T Cell-Mediated Cytotoxicity
- (2013) Matilde Todaro et al. PLoS One
- What lessons can be learned from γδ T cell-based cancer immunotherapy trials?
- (2012) Jean-Jacques Fournié et al. Cellular & Molecular Immunology
- Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma
- (2011) Joshua M. Lang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Stimulated T Cells Increase the In Vivo Efficacy of Trastuzumab in HER-2+ Breast Cancer
- (2011) A.-H. Capietto et al. JOURNAL OF IMMUNOLOGY
- Preferential Th1 Cytokine Profile of Phosphoantigen-Stimulated Human Vγ9Vδ2 T Cells
- (2011) Margaret R. Dunne et al. MEDIATORS OF INFLAMMATION
- Evolution of the V, D, and J gene segments used in the primate T-cell receptor reveals a dichotomy of conservation and diversity
- (2011) A. R. Kazen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vγ9Vδ2 T lymphocyte agonist in patients with solid tumors
- (2010) Jaafar Bennouna et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- In vivo manipulation of Vγ9Vδ2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients
- (2010) S. Meraviglia et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies
- (2009) J. Gertner-Dardenne et al. BLOOD
- IL-21-Mediated Potentiation of Antitumor Cytolytic and Proinflammatory Responses of Human V 9V 2 T Cells for Adoptive Immunotherapy
- (2009) A. Thedrez et al. JOURNAL OF IMMUNOLOGY
- Intravesical administration of γδ T cells successfully prevents the growth of bladder cancer in the murine model
- (2008) Takeshi Yuasa et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started